LPT

PREIT Completes Financial Restructuring and Implements Changes to Management and Board

Retrieved on: 
Monday, April 1, 2024
Management, Bankruptcy, Plan, Howard Hughes Corporation, JV, LPT, COVID-19, FDP, PREIT, Brookfield Properties, Vicinity Centres, The Rouse Company, International Council, Realty Income, VEREIT, GGP, ICSC, Fashion District Philadelphia, LP

Trade creditors and property level mortgage debt were unaffected by the restructuring.

Key Points: 
  • Trade creditors and property level mortgage debt were unaffected by the restructuring.
  • As a result of its corporate reorganization and consolidation of equity holders, PREIT is no longer an SEC reporting company.
  • In support of its go-forward business plan, PREIT is also announcing certain changes to its management and Board.
  • Mr. Coradino led PREIT through its comprehensive financial and corporate restructuring as discussed above, and now that such restructuring has been successfully completed, Mr. Coradino will no longer serve as Chief Executive Officer and trustee of PREIT, effective as of April 1, 2024.

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

Retrieved on: 
Monday, April 1, 2024
Sky Global, LPT, Gross income, Beauty, Patient, Operating cost, CBD, Bank statement, OTC, Chronic pain, FDA, Pharmaceutical industry

This significant increase in revenue was primarily due to the robust sales performance of Innocan's subsidiary, BI Sky Global Ltd.

Key Points: 
  • This significant increase in revenue was primarily due to the robust sales performance of Innocan's subsidiary, BI Sky Global Ltd.
  • Gross Profit increased 568% year-over-year to US$12.0 million for the year ended December 31, 2023, compared to US$2.1 million for 2022.
  • Iris Bincovich, the CEO of Innocan commented: "We are very pleased with our performance in 2023, closing the year with a strong fourth quarter.
  • Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "Our consumer wellness products are trusted by millions of customers.

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million

Retrieved on: 
Friday, March 15, 2024
Indian stock exchange, LPT, Sale, Regulation, News, Person, NOT, FDA, RSU, Security (finance)

HERZLIYA, Israel and CALGARY, Alberta, March 14, 2024 /PRNewswire/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the "Offering") of units of the Company (the "Units"), pursuant to which the Company issued 7,952,840 Units at a price of $0.25 per Unit (the "Offering Price") for aggregate gross proceeds of $1,988,210. 

Key Points: 
  • Each Unit is comprised of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant").
  • This successful financing is another illustration of the confidence and trust that the investment community has in the future milestones of Innocan.
  • The Company intends to use the proceeds from the Offering for working capital and general corporate purposes.
  • Each RSU entitles the recipient to receive one common share of the Company (a "Common Share") on vesting.

OTC Markets Group Upgrades Three Grayscale Products to OTCQX

Retrieved on: 
Thursday, March 7, 2024
Livepeer, Bitcoin, Bitcoin Cash, Decentraland, Ethereum, Ethereum Classic, ZEN, Litecoin, Stellar, Basic Attention Token, BAT, LINK, LPT, ZEC, FIL, BCH, LTC, ETH, MANA, ETC, OTCQX, XLM, SOL, Research, Decentralized finance, Grayscale, Cryptocurrency

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Grayscale Chainlink Trust (LINK) (OTCQX: GLNK), Grayscale Livepeer Trust (LPT) (OTCQX: GLIV) and Grayscale Solana Trust (SOL) (OTCQX:GSOL), have qualified to trade on the OTCQX® Best Market.

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Grayscale Chainlink Trust (LINK) (OTCQX: GLNK), Grayscale Livepeer Trust (LPT) (OTCQX: GLIV) and Grayscale Solana Trust (SOL) (OTCQX:GSOL), have qualified to trade on the OTCQX® Best Market.
  • Grayscale Chainlink Trust (LINK), Grayscale Livepeer Trust (LPT) and Grayscale Solana Trust (SOL) begin trading today on OTCQX under the symbols “GLNK, GLIV, and GSOL” respectively.
  • These three products will join nine other Grayscale products currently trading on OTCQX: Grayscale Bitcoin Cash Trust (BCH), Grayscale Decentraland Trust (MANA), Grayscale Digital Large Cap Fund LLC, Grayscale Ethereum Trust (ETH), Grayscale Ethereum Classic Trust (ETC), Grayscale Horizen Trust (ZEN), Grayscale Litecoin Trust (LTC), Grayscale Stellar Lumens Trust (XLM), and Grayscale Zcash Trust (ZEC).
  • To round out a total of fifteen Grayscale products on the OTC Markets, Grayscale Basic Attention Token Trust (BAT), Grayscale Decentralized Finance (DeFi) Fund LLC, and Grayscale Filecoin Trust (FIL) trade on the OTCQB Market.

Skyward Specialty Insurance Group Reports Fourth Quarter 2023 Results

Retrieved on: 
Tuesday, February 20, 2024
Transfer, Interest, GAAP, LPT, PIN, Nature, Insurance, Policy, Partnership, Renewable energy

(1) excludes income from operating cash for the fourth quarter and years ended December, 31, 2023 and 2022.

Key Points: 
  • (1) excludes income from operating cash for the fourth quarter and years ended December, 31, 2023 and 2022.
  • Net investment income for our investment portfolio for the fourth quarter and year ended 2023 increased $8.1 million and $2.9 million, respectively, when compared to the same 2022 periods.
  • The opportunistic fixed income portfolio continued to be impacted by a decline in the fair value of limited partnership investments for the fourth quarter of 2023 and 2022 and for the year ended 2023.
  • At 9 a.m. central standard time tomorrow, February 21, 2024, Skyward Specialty management will hold a conference call to discuss quarterly results with insurance industry analysts.

SiriusPoint reports 89.1% Combined ratio for its Core operations with Net Income up $742m from FY 22

Retrieved on: 
Tuesday, February 20, 2024
Acquisition, Total, LPT, Risk, Annual report, Investment, Asbestos, Growth, Rotation, Government, Hurricane Ian, Insurance, GAAP, COVID-19, Consolidated, Tax, Security (finance), Corporation, Internet, Cryptocurrency

(1) Core underwriting income (loss), Core net services income, Core income and Core combined ratio are non-GAAP financial measures.

Key Points: 
  • (1) Core underwriting income (loss), Core net services income, Core income and Core combined ratio are non-GAAP financial measures.
  • Core underwriting income, Core net services income, Core income and Core combined ratio are non-GAAP financial measures.
  • Income for the three months ended December 31, 2023 consists of underwriting income of $37.0 million (93.4% combined ratio) and net services income of $9.3 million, compared to underwriting income of $31.2 million (94.8% combined ratio) and net services income of $2.8 million for the three months ended December 31, 2022.
  • Core underwriting income, Core net services income, Core income, and Core combined ratio are non-GAAP financial measures.

AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of Triple-S Propiedad, Inc.

Retrieved on: 
Friday, March 8, 2024
Banking, Professional Services, Insurance, Finance, TSP, ERM, LPT, ALL, News, AM Best, Guaynabo, Puerto Rico, Risk, Weakness, Good, Credit, GuideWell, Hurricane Maria, Risk management

The outlook assigned to these Credit Ratings (ratings) is stable.

Key Points: 
  • The outlook assigned to these Credit Ratings (ratings) is stable.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

Retrieved on: 
Tuesday, March 5, 2024
Regeneration, Regulation, LPT, Person, Blood, Pathology, News, Cannabidiol, Animal, Dog, Schizophrenia, Sheep, Stroke, Goat, Indian stock exchange, Unit, Pharmacokinetics, Rabbit, DSM-IV codes, Spectrum, B.B.B, Mouse, Brain, Medical imaging

HERZLIYA, Israel and CALGARY, Alberta, March 5, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, is pleased to announce the following:

Key Points: 
  • In the Company's latest study, CBD was found to be in the brains of both mice and rabbits weeks after LPT-CBD was subcutaneously injected to them.
  • These results show a strong correlation between the prolonged blood exposure of CBD and its brain distribution.
  • Sufficient exposure of CBD in the brain is the hallmark of CBD therapy associated with various neurological conditions.
  • The fact that LPT-CBD successively delivers CBD to the brain in a long-lasting manner opens a big venue for the treatment of various neurological disorders.

Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits

Retrieved on: 
Monday, February 26, 2024
AB, LPT, CMAX, Blood, Animal, Dog, Sheep, Goat, Tmax, Pharmacokinetics, Rabbit, Half-life, Mouse

The fundamentals of LPT-CBD lay in its ability to slowly release CBD into the blood stream.

Key Points: 
  • The fundamentals of LPT-CBD lay in its ability to slowly release CBD into the blood stream.
  • In the Company's latest study conducted on rabbits, the results showed additional supportive data for the long exposure of CBD obtained following a single subcutaneous LPT-CBD injection.
  • The Company is encouraged by these study results as they confirm the approach the Company is taking with its LPT platform.
  • In the study conducted on rabbits, the animals were collected for blood analysis of the drug for up to 11 days.

Top Arizona Real Estate Team Switches to LPT Realty for Strategic Growth

Retrieved on: 
Wednesday, February 21, 2024
Marketing, Dream, LPT, Real estate

PHOENIX, Feb. 21, 2024 /PRNewswire/ -- KP Elite | Zaback Group, Arizona's #1 real estate team with over $500 million in production, announces a groundbreaking transition from EXP Realty to launch LPT Realty in Arizona.

Key Points: 
  • PHOENIX, Feb. 21, 2024 /PRNewswire/ -- KP Elite | Zaback Group, Arizona's #1 real estate team with over $500 million in production, announces a groundbreaking transition from EXP Realty to launch LPT Realty in Arizona.
  • With ambitions to enlist 1,000 agents in Arizona by the end of 2024, LPT Realty is poised to redefine the real estate brokerage model.
  • Launching LPT in Arizona is all about bringing new opportunities to real estate professionals who have been waiting for a change."
  • LPT Realty's entry into the Arizona real estate market, led by KP Elite | Zaback Group, ushers in a new era of real estate brokerage services.